2024-04-25  10:09:07 AM Chg. +0.06 Volume Bid10:09:08 AM Ask10:09:08 AM Market Capitalization Dividend Y. P/E Ratio
2.74HKD +2.24% 90.19 mill.
Turnover: 232.33 mill.
2.74Bid Size: 278,000 2.75Ask Size: 2.24 mill. 53.18 bill.HKD - -

Business description

Sino Biopharmaceutical Limited, together with its subsidiaries, is a research and development driven pharmaceutical conglomerate in the Republic of China. Its business encompasses a fully integrated chain in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver disease, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedic diseases. In order to enhance our sustainable competitiveness, the Group attaches great importance to R&D breakthroughs and is positioned as an industry leader in terms of R&D expenditures and product innovation.
 

Management board & Supervisory board

CEO
Tse Eric SY
Management board
Li Chunling, Theresa Tse, Tse Hsin, Chen,Sean, Ben Toogood, Jin Song, George Orphanides
Supervisory board
Cheng Cheung Ling, Theresa Tse, Tse, Eric S Y, Tse Hsin, Tian Zhoushan, Li Mingqin, Lu Zhengfei, Li Dakui, Lu Hong, Zhang Lu Fu, LI Kwok Tung Donald
 

Company data

Name: Sino Biopharmaceutical Ltd.
Address: Rm 4109, Office Tower, Convention Plaza, 1 Harbour Road,Wanchai, Hong Kong
Phone: +852-2802-9886
Fax: +852-2880-0847
E-mail: info@sino-biopharm.com
Internet: www.sinobiopharm.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12-31
Free Float: 51.86%
IPO date: 2003-12-08

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: -

Main Shareholders

Others
 
50.78%
Tse SY
 
21.54%
Theresa Tse
 
12.13%
Ping Tse
 
8.82%
Cheung Ling Cheng
 
4.72%
The Vanguard Group, Inc.
 
2.01%